Stay updated on CD123xCD3 DuoBody Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.

Latest updates to the CD123xCD3 DuoBody Dose Escalation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows Revision: v3.4.2 replacing v3.4.1; no study data, descriptions, or records were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe history page now shows a new revision entry (v3.4.1) and removes v3.4.0, reflecting a minor metadata update to the revision history. This change does not affect core content, functionality, or user experience; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page history. This is a minor version-label update and does not affect study data, eligibility criteria, or page functionality.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision label 'Revision: v3.3.3' was added and the previous 'Revision: v3.3.2' entry was removed, along with the 'HHS Vulnerability Disclosure' notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision history now includes a new entry for v3.3.2 and removes v3.2.0 from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved a generic government funding/operating status notice from the page; this change does not affect core study details or status information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to CD123xCD3 DuoBody Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.